Skip to main content
. 2022 Jan 15;2:130–136. doi: 10.1016/j.ijregi.2022.01.002

Table 3.

Seroprevalence of anti-SARS-CoV-2 antibodies, stratified by age group.

Age group IgG IgM
18–24 years 20/71 (28.2%) 7/71 (9.9%)
25–34 years 22/87 (25.3%) 8/87 (9.2%)
35–44 years 15/41 (36.6%) 3/41 (7.3%)
45–60 years 16/42 (38.1%) 8/42 (19.0%)
p-value 0.37 0.29